Save your place

Sign in to WhoBought

Please try again later.

X4 Pharmaceuticals, Inc. (XFOR) institutional ownership

Latest close $3.69 Jul 21, 2026
Market cap$49M 52-week range SectorHealthcare
Funds holding · Q1 2026
71
reported XFOR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
37 buyers · 34 sellers

X4 Pharmaceuticals, Inc. (XFOR) price and institutional activity

Dates

Q1 2026

$0 bought by 37 investors
Deep Track Capital, LPMorgan Stanley +35 more
$0 sold by 34 investors
Siren, L.L.C.Point72 Asset Management, L.P. +32 more
Bought Sold Totals per quarter; hover a bar for the names.

X4 Pharmaceuticals, Inc. (XFOR) institutional activity · 71

Investor Type Est. change Change Δ Own Date
Siren, L.L.C. · Exited
Change −1.5M Δ Own −100.0% Date Q1 2026
Siren, L.L.C. Exited· Q1 2026 −1.5M −100.0% Q1 2026
Deep Track Capital, LP · Added
Change +1.3M Date Q1 2026
Deep Track Capital, LP Added· Q1 2026 +1.3M Q1 2026
Morgan Stanley · Added
Change +1.3M Date Q1 2026
Morgan Stanley Added· Q1 2026 +1.3M Q1 2026
Millennium Management LLC · Added
Change +1.2M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +1.2M Q1 2026
Susquehanna International Group, LLP · Added
Change +834K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +834K Q1 2026
Point72 Asset Management, L.P. · Exited
Change −808K Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −808K −100.0% Q1 2026
Saturn V Capital Management LP · Added
Change +656K Date Q1 2026
Saturn V Capital Management LP Added· Q1 2026 +656K Q1 2026
Rosalind Advisors, Inc. · Added
Change +609K Date Q1 2026
Rosalind Advisors, Inc. Added· Q1 2026 +609K Q1 2026
Vanguard · Added
Change +599K Date Q1 2026
Vanguard Added· Q1 2026 +599K Q1 2026
Perceptive Advisors LLC · Added
Change +423K Date Q1 2026
Perceptive Advisors LLC Added· Q1 2026 +423K Q1 2026
FMR LLC · Reduced
Change −396K Δ Own −4.7% Date Q1 2026
FMR LLC Reduced· Q1 2026 −396K −4.7% Q1 2026
Silverarc Capital Management, LLC · Exited
Change −357K Δ Own −100.0% Date Q1 2026
Silverarc Capital Management, LLC Exited· Q1 2026 −357K −100.0% Q1 2026
Venrock Adviser, LLC · New
Change +331K Date Q1 2026
Venrock Adviser, LLC New· Q1 2026 +331K Q1 2026
UBS Group AG · Added
Change +263K Date Q1 2026
UBS Group AG Added· Q1 2026 +263K Q1 2026
Stonepine Capital Management, LLC · Reduced
Change −258K Date Q1 2026
Stonepine Capital Management, LLC Reduced· Q1 2026 −258K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 71

Famous investor activity in X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals, Inc. (XFOR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Gold Kelly · Director Grant (A) 110K
Owned 110K Trade date Jul 1, 2026 Filed date Jul 1, 2026
Gold Kelly Director Grant (A) 110K 110K Jul 1, 2026 Jul 1, 2026
Kirske David · Officer Sell −$36K
Price $4.26 Qty −9K Owned 168K ΔOwn −4.8% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Kirske David Officer Sell $4.26 −9K −$36K 168K −4.8% Jun 30, 2026 Jul 1, 2026
Kirske David · CFO Sell −$73K
Price $4.29 Qty −17K Owned 176K Trade date May 12, 2026 Filed date May 13, 2026
Kirske David CFO Sell $4.29 −17K −$73K 176K May 12, 2026 May 13, 2026
Bridger Gary · Director Grant (A) 110K
Owned 0 Trade date Jan 1, 2026 Filed date Jan 7, 2026
Bridger Gary Director Grant (A) 110K 0 Jan 1, 2026 Jan 7, 2026
De Craecker Francoise · Director Grant (A) 110K
Owned 0 Trade date Jan 1, 2026 Filed date Jan 5, 2026
De Craecker Francoise Director Grant (A) 110K 0 Jan 1, 2026 Jan 5, 2026
Wyzga Michael S. · Director Grant (A) 110K
Owned 0 Trade date Jan 1, 2026 Filed date Jan 5, 2026
Wyzga Michael S. Director Grant (A) 110K 0 Jan 1, 2026 Jan 5, 2026
Stewart Murray · Director Grant (A) 110K
Owned 0 Trade date Jan 1, 2026 Filed date Jan 5, 2026
Stewart Murray Director Grant (A) 110K 0 Jan 1, 2026 Jan 5, 2026
Craig Adam R. · Director Grant (A) 2.3M
Owned 2.3M Trade date Oct 29, 2025 Filed date Oct 31, 2025
Craig Adam R. Director Grant (A) 2.3M 2.3M Oct 29, 2025 Oct 31, 2025
Volpone John · Officer Grant (A) 2.3M
Owned 2.3M Trade date Oct 29, 2025 Filed date Oct 31, 2025
Volpone John Officer Grant (A) 2.3M 2.3M Oct 29, 2025 Oct 31, 2025
Kirske David · Officer Grant (A) 1.6M
Owned 1.6M Trade date Oct 29, 2025 Filed date Oct 31, 2025
Kirske David Officer Grant (A) 1.6M 1.6M Oct 29, 2025 Oct 31, 2025
Craig Adam R. · Director, Officer Buy +$250K
Price $2.90 Qty +86K Owned 376K Trade date Oct 23, 2025 Filed date Oct 27, 2025
Craig Adam R. Director, Officer Buy $2.90 +86K +$250K 376K Oct 23, 2025 Oct 27, 2025
Volpone John · Officer 2 operations 819K
Owned 529K Trade date Aug 14, 2025 Filed date Aug 14, 2025
Volpone John Officer 2 operations 819K 529K Aug 14, 2025 Aug 14, 2025
Craig Adam R. · Director 2 operations 819K
Owned 529K Trade date Aug 14, 2025 Filed date Aug 14, 2025
Craig Adam R. Director 2 operations 819K 529K Aug 14, 2025 Aug 14, 2025
Kirske David · Officer 2 operations 546K
Owned 353K Trade date Aug 14, 2025 Filed date Aug 14, 2025
Kirske David Officer 2 operations 546K 353K Aug 14, 2025 Aug 14, 2025
Volpone John · Officer Grant (A) 1.6M
Owned 1.6M Trade date Aug 12, 2025 Filed date Aug 14, 2025
Volpone John Officer Grant (A) 1.6M 1.6M Aug 12, 2025 Aug 14, 2025
15 of 17
15 of 17 Sign in to continue to older insider transactions.

X4 Pharmaceuticals, Inc. (XFOR) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Empery Asset Management, LP 9.0M
% of shares outstanding 10.0% Filing date Jan 15, 2026
Empery Asset Management, LP 9.0M 10.0% Jan 15, 2026
Coastlands Capital LP 2.5M
% of shares outstanding 10.0% Filing date Oct 3, 2025
Coastlands Capital LP 2.5M 10.0% Oct 3, 2025
Deep Track Capital, LP 2.4M
% of shares outstanding 10.0% Filing date Aug 19, 2025
Deep Track Capital, LP 2.4M 10.0% Aug 19, 2025
Growth Equity Opportunities 18 Vge, LLC 15.7M
% of shares outstanding 10.0% Filing date May 26, 2023
Growth Equity Opportunities 18 Vge, LLC 15.7M 10.0% May 26, 2023
FMR LLC 8.5M
% of shares outstanding 9.7% Filing date Feb 5, 2026
FMR LLC 8.5M 9.7% Feb 5, 2026
Saturn V Capital Management LP 6.4M
% of shares outstanding 7.4% Filing date Feb 17, 2026
Saturn V Capital Management LP 6.4M 7.4% Feb 17, 2026
Perceptive Advisors LLC 6.9M
% of shares outstanding 7.3% Filing date May 15, 2026
Perceptive Advisors LLC 6.9M 7.3% May 15, 2026
Blackrock, Inc. 11.2M
% of shares outstanding 6.7% Filing date Nov 8, 2024
Blackrock, Inc. 11.2M 6.7% Nov 8, 2024
8 of 18

X4 Pharmaceuticals, Inc. (XFOR) ownership FAQ

Who owns XFOR?

71 reporting institutions disclosed XFOR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.